Sichuan Qingmu Pharmaceutical
Meishan, Sichuan, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Sichuan Qingmu Pharmaceutical
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Meishan, Sichuan, China
- Website
- https://www.qingmupharm.com/cdmo-services
- Modalities
- Small Molecule API, High-Potency APIs, Cytotoxics, Oligonucleotide
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Sichuan Qingmu Pharmaceutical
Sichuan Qingmu Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, High-Potency APIs, Cytotoxics, Oligonucleotide. 1 manufacturing site registered with the U.S. FDA. Website: https://www.qingmupharm.com/cdmo-services
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Sichuan Qingmu Pharmaceutical FDA Inspection History
2025-10
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-10-24 |
Sichuan Qingmu Pharmaceutical Co., Ltd
Meishan
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Sichuan Qingmu Pharmaceutical
How many FDA inspections does Sichuan Qingmu Pharmaceutical have on record?
CDMO Signal tracks 1 FDA inspection for Sichuan Qingmu Pharmaceutical, sourced from the FDA inspection database. See the full inspection history above.
Has Sichuan Qingmu Pharmaceutical received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Sichuan Qingmu Pharmaceutical.
Does Sichuan Qingmu Pharmaceutical have a CDMO Signal Score?
Not yet. Sichuan Qingmu Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Sichuan Qingmu Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Sichuan Qingmu Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Fermion
Espoo, Finland
Small Molecule API, High-Potency APIs, Cytotoxics, Oral Solid Dose, Sterile Injectables, Semi-solids & Liquids
Fujimoto Chemicals
Osaka, Japan
Small Molecule API, High-Potency APIs, Oligonucleotide
Kolon Life Science
Gwacheon, South Korea
Small Molecule API, Intermediates, Oligonucleotide, High-Potency APIs
Anax Laboratories
Hyderabad, Telangana, India
Small Molecule API, High-Potency APIs, Peptides, Oligonucleotide, ADC / Bioconjugation, Custom Synthesis
Compare Sichuan Qingmu Pharmaceutical with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.